Dr David Dodwell
David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
David is a senior breast oncologist with a number of research and governance interests.
He is the lead oncologist on the Sloane and NHS breast screening audits and co-lead for the national audits in primary and metastatic breast cancer.
Recent publications
The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report.
Journal article
Hanbury G. et al, (2026), Clin Oncol (R Coll Radiol), 52
Reducing locoregional treatments in low risk early invasive breast cancer.
Journal article
Potter S. et al, (2026), Eur J Surg Oncol, 52
Impact of sex on chemotherapy toxicity and efficacy in biliary tract cancer: Analysis of ABC, BILCAP trials and population data.
Journal article
Wagner AD. et al, (2026), JHEP Rep, 8
Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-Analysis.
Journal article
Kazmi F. et al, (2025), Clin Oncol (R Coll Radiol), 48
Local management of second breast cancer event after primary breast conserving therapy: The patient's perspective.
Journal article
Hannoun-Levi J-M. et al, (2025), Eur J Surg Oncol, 51

